Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial
Emily L. Sammons, Georgina Buck, Louise J. Bowman, William M. Stevens, Imen Hammami, Sarah Parish, Jane Armitage, on behalf of the ASCEND Study Collaborative Group · 2024
Read Effects of aspirin and omega-3 fatty acids on composite and subdomain scores from the NEI-VFQ-25 questionnaire: the ASCEND-Eye randomized controlled trial by Emily L. Sammons, Georgina Buck, Louise J. Bowman, William M. Stevens, Imen Hammami, Sarah Parish, Jane Armitage, on behalf of the ASCEND Study Collaborative Group (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11536542.txt.
Description
Emily Sammons and co-authors reported the eye results of a big prevention trial in a 2024 paper. The ASCEND trial had randomized 15,480 British adults with diabetes to daily aspirin, omega-3 fatty acids, both, or neither, in a two-by-two design, to test heart protection. The eye sub-study asked whether seven and a half years of either treatment changed how participants themselves rated their vision, using a standard 25-item questionnaire.
Neither aspirin nor omega-3 moved the overall score or any sub-score in a meaningful way. The null result is itself informative: supplements taken for the heart did not quietly help or harm eyesight as patients experience it. The dataset, among the largest of its kind in diabetes, will support further work on who ends up with poor vision scores and why.
Catalog record
| CREATOR | Emily L. Sammons, Georgina Buck, Louise J. Bowman, William M. Stevens, Imen Hammami, Sarah Parish, Jane Armitage, on behalf of the ASCEND Study Collaborative Group |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |